The emergence of new immunotherapies as the first line of treatment for cancer necessitates the development of clinically useful biomarkers to identify patients who will benefit.

In this webinar, immunohistochemist Patrick Savickas and Akoya Biosciences senior application scientist Ning Ma will discuss spatial signatures — biomarkers based on spatial relationships and protein co-expression on specific cellular subsets that are assessed within the context of the tumor immune microenvironment, which have demonstrated higher accuracy in predicting response to immunotherapies. Savickas will discuss his experience with Akoya’s new multiplex panels based on novel protein chemistry that can accelerate the development of spatial signatures, simplifying the pathway to improved stratification to immunotherapy response.